Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,632.19
(
-0.61%
)
US TECH 100
23,737.60
(
-0.64%
)
Dow Jones
46,558.47
(
-0.26%
)
Brent Oil
101.58
(
0.00%
)
Bitcoin
70,721.00
(
-0.34%
)
News Focus
News Focus
Post# of 159
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Cameo Brien

Send PM Follow Ignore
Followers 124
Posts 14796
Boards Moderated 0
Alias Born 04/26/2013

Cameo Brien

Re: None

Saturday, 07/12/2025 7:41:09 AM

Saturday, July 12, 2025 7:41:09 AM

Post# of 159
Strong Clinical Pipeline: CVKD is advancing neflamapimod, an oral therapy targeting p38 alpha kinase, with promising data in dementia with Lewy bodies (DLB)—a condition with no FDA-approved treatments.

***FOLLOW FOR ALERTS***

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent CVKD News
More CVKD News
InvestorsHub NewsWire

Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM

DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM

Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM

C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM

RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM

BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM

Start posting your company's news
Only $200 per official company press release!